#DYK Allergic asthma is primarily driven by abnormal T helper (Th2) cells, where interleukin receptors and STAT6, a crucial transcription factor, play central roles in inflammation and disease progression. A major hurdle in asthma treatment is the lack of biocompatible vectors for efficient siRNA delivery to target cells. Join AAPS tomorrow as Mahavir Bhupal Chougule, Ph.D., of Mercer University, presents a study using receptor-guided STAT6 siRNA-loaded gelatin #nanocarriers conjugated with a targeting peptide to selectively deliver siRNA to T cells.

All AAPS members receive access to numerous archived AAPS #webinars similar to this along with many other high-value benefits.